We’re moving into a prime advocacy period. This is the second of a series of blogs on advocacy that are going to appear over the next month. The first focused on the big advocacy event of the year – the Solve ME/CFS Initiative’s Lobby Day. If...
An impaired baroreflex response could be contributing to the pain, fatigue, sleep and cognitive issues in fibromyalgia, chronic fatigue syndrome and postural orthostatic tachycardia syndrome (POTS)
Virtual Lobby Day and Lobby Week is fast approaching, but this is not your average Lobby Day. In fact, we may not see its like again. The stars have finally been aligning for us. Long COVID is a hot subject – it just got over a billion dollars in funding....
A retrospective study suggests that low dose Abilify is safe and may be helpful in reducing fatigue and post-exertional malaise and improving cognition and sleep in chronic fatigue syndrome. A placebo-controlled study is needed to determine how effective low dose Abilify is.
A BIG thanks to everyone whose contributions helped make Health Rising's summer drive a success :)
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.